Google News

Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M - BioPharma Dive

Aug 6, 2026, 7:14 PM

Translate article text

Choose a language and wait for the translated text.

Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M  BioPharma Dive